pMD®️ Unveils New Branding To Improve Transparency And Value For Customers
Streamlined product offerings reinforce pMD’s dedication to unparalleled customer service pMD Product Rebranding – Images…
Streamlined product offerings reinforce pMD’s dedication to unparalleled customer service pMD Product Rebranding – Images…
DC-Based Electrification AcceleratorTM Adds Key Executives to Meet Growing Demand for Vendor-Neutral EV Fleet Management…
MONMOUTH JUNCTION, N.J., Aug. 24, 2023 (GLOBE NEWSWIRE) — Elucida Oncology, a clinical-stage biotechnology company…
Rapid adoption by customer and employee experience-centric businesses leads to unprecedented growth for branded calling…
DENVER, Aug. 24, 2023 (GLOBE NEWSWIRE) — Pax8, the leading cloud commerce marketplace, announced today…
New unlimited patching possibilities enable audio engineers to elevate their vision for live production Avid’s…
Toronto, Ontario–(Newsfile Corp. – August 24, 2023) – BeWhere (TSXV: BEW) (OTCQB: BEWFF) (“BeWhere” or…
HONG KONG, Aug 24, 2023 – (ACN Newswire) – Ocumension Therapeutics (“Ocumension” or the “Company”,…
PCFCU’s partnership with Agent IQ recognized for its measurable success, efficient AI automation and self-service…
Genesis Ranks Highest Overall for Tech Innovation for Third Consecutive Year; Hyundai Ranks Highest among…
An index-tracking ETF that provides exposure to companies with high free cash flow yield WHEATON,…
Prestigious International Annual Awards Program Recognizes Standout Marketing, Advertising, and Sales Technology Around the World…
dotData Ops democratizes enterprise AI and ML, empowering BI & Analytics professionals with streamlined data,…
– Board of Director appointments follow the Company’s recent launch and $200 million Series A…
– Board of Director appointments follow the Company’s recent launch and $200 million Series A…
Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. – or 1 out…
Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. – or 1 out…
First Antiviral Drug in Glycovirology BOSTON, MASSACHUSETTS, Aug. 24, 2023 (GLOBE NEWSWIRE) — BIOXYTRAN, INC….
First Antiviral Drug in Glycovirology BOSTON, MASSACHUSETTS, Aug. 24, 2023 (GLOBE NEWSWIRE) — BIOXYTRAN, INC….
COPENHAGEN, Denmark, Aug. 24, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced…